Search Results:  Science and Technology  (7)

  • 172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility

    • Nine CEPI-supported candidate vaccines are part of the COVAX initiative, with a further nine candidates under evaluation, and procurement conversations on-going with additional producers not currently receiving research and development (R&D) funding through COVAX – giving COVAX the largest and most diverse COVID-19 vaccine portfolio in the world
    • 80 potentially self-financing countries have submitted non-binding expressions of interest to the Gavi-coor

      Roles: Everyone: All Users

      Regions: Afghanistan, Argentina, Canada , Chile, China, France , Ireland , Norway , Tonga , United Kingdom , United States , West Bank , Zambia

      Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Energy, Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

    • Mexico’s feat against rabies through cross-sectoral collaboration is possible in other countries

      Mexico is, so far, the only country validated by the World Health Organization (WHO) for having eliminated dog-mediated human rabies as a public health problem. To encourage countries that have implemented elimination programmes as recommended by WHO and the Organisation for Animal Health (OIE), international procedures have been developed jointly by WHO and OIE, following a One Health approach. The procedures involve several steps in the preparation, submission and review of a dossier.

      Roles: Everyone: All Users

      Regions: Mexico

      Topics: Climate and Environment, Global Health, Science, Technology, and Innovation

    • More than 150 countries engaged in COVID-19 vaccine global access facility

      Results 1 - 7 of 7

  • Regions









































































































































































































































  • Topics